Its inhibition could lead to LAP impairment and subsequently result in a decrease in M2-like tumor associated macrophages and a switch in the expression of immunosuppressive cytokines to immunostimulatory cytokines (98). This evidence concerns the gene TGFB1 and neoplasm.